Prothena
PRTA
#7628
Rank
NZ$0.78 B
Marketcap
NZ$15.02
Share price
0.92%
Change (1 day)
43.27%
Change (1 year)

Earnings for Prothena (PRTA)

Earnings in 2026 (TTM): -NZ$0.16 Billion

According to Prothena's latest financial reports the company's current earnings are NZ$57.94 Million. In 2025 the company made an earning of -NZ$0.32 Billion a decrease over its 2024 earnings that were of -NZ$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Prothena from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.16 Billion-50.71%
2025 -NZ$0.32 Billion19.41%
2024 -NZ$0.27 Billion-19.09%
2023 -NZ$0.33 Billion45.21%
2022 -NZ$0.23 Billion-282.78%
2021 NZ$0.12 B-163.84%
2020 -NZ$0.2 Billion33.94%
2019 -NZ$0.15 Billion-44.78%
2018 -NZ$0.27 Billion-0.97%
2017 -NZ$0.27 Billion-3.33%
2016 -NZ$0.28 Billion99.17%
2015 -NZ$0.14 Billion1102.24%
2014 -NZ$11.42 Million-83.55%
2013 -NZ$69.4 Million-2.37%
2012 -NZ$71.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amarin Corporation
AMRN
-NZ$53.46 Million-66.58%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Alnylam Pharmaceuticals
ALNY
NZ$1.49 B-1,033.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$0.40 B-354.54%๐Ÿ‡ฎ๐Ÿ‡ช Ireland